Clinical Trial Update: Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications [Phase 1]

View source ↗

Summary

A Phase 1 trial update describes modifications to a study using autologous, genetically modified lymphocytes to treat HIV in HIV-infected identical twins. The c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Genetically modified lymphocytes (autologous genetically modified T cells)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acquired Immunodeficiency Syndrome, HIV Infection | Phase 1 | Status: COMPLETED